A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
It can pick cancer cells out of a blood sample and let them go later, enabling further tests that can show whether the therapy is successfully ridding the patient of the most dangerous cancer cells.
